Loading...
The efficacy, safety and ethics of the use of testosterone-suppressing agents in the management of sex offending
Mashru, Asha
Mashru, Asha
Abstract
PURPOSE OF REVIEW: The use of endocrine medications to reduce sexual offending recidivism is established and may involve clinicians from diverse specialities. The present review aims to outline relevant background information and note a Medical Ethics framework upon which to facilitate decision-making.
RECENT FINDINGS: There have been several systematic reviews in recent years. A number of problems with research in the area of the medical treatment of sex offenders have been highlighted. There remains scope for improvement in the research to answer a number of relevant clinical issues. Nonetheless, some very useful indicators of relevance to clinical practice have emerged.
SUMMARY: The use of medication to manage the risk of sex offending in males is appropriate under the right circumstances. These include, for example, hypersexuality with sexual deviance and psychological-treatment interfering sexual preoccupation.
RECENT FINDINGS: There have been several systematic reviews in recent years. A number of problems with research in the area of the medical treatment of sex offenders have been highlighted. There remains scope for improvement in the research to answer a number of relevant clinical issues. Nonetheless, some very useful indicators of relevance to clinical practice have emerged.
SUMMARY: The use of medication to manage the risk of sex offending in males is appropriate under the right circumstances. These include, for example, hypersexuality with sexual deviance and psychological-treatment interfering sexual preoccupation.
MIDER Authors
Citations
Altmetric:
Date
2016
Type
Article
Subject
Drug therapy, Criminals, Sex offenses
Collections
Citation
Khan, O. & Mashru, A. (2016). The efficacy, safety and ethics of the use of testosterone-suppressing agents in the management of sex offending. Current Opinion in Endocrinology, Diabetes and Obesity, 23 (3), pp.271-278.
Journal / Source Title
DOI
PMID
Publisher
Publisher’s URL
Publisher’s statement
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
Files
Loading...
Khan 2016 271-278.pdf
Adobe PDF, 2.77 MB